PKO Investment Management Joint-Stock’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,469,609	Closed	-$5M	–	95
2018 Q3	$5M	Hold	1,469,609	–	–	1%	25
2018 Q2	$5.53M	Buy	+1,469,609	New	+$7.16M	1.15%	22

PKO Investment Management Joint-Stock's KERX Position: Q4 2018 in Review

PKO Investment Management Joint-Stock sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 1,469,609 shares — an estimated $5M sold.

PKO Investment Management Joint-Stock first reported a position in KERX in Q2 2018 and held it in 2 quarters. The position peaked at $5.53M in Q2 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

PKO Investment Management Joint-Stock reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
PKO Investment Management Joint-Stock sold 1,469,609 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $5M.
PKO Investment Management Joint-Stock first reported a position in Keryx Biopharmaceuticals Inc in Q2 2018 and held it in 2 quarters.
PKO Investment Management Joint-Stock's Keryx Biopharmaceuticals Inc position peaked at $5.53M in Q2 2018.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on PKO Investment Management Joint-Stock's 13F filing for Q4 2018, filed 13 Mar 2025.